-
2 months ago | 
mdpi.com | Elvira Agrón |Emily Vance |Amitha Domalpally |Emily Y. Chew
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Dec 4, 2024 | 00206-9/fulltext&sz=64)
ophthalmologyscience.org | Clinical Applications |Cameron Duic |Emily Y. Chew |Catherine Cukras
Keywordsage-related macular degenerationartificial intelligencespectral-domain optical coherence tomographyHeidelberg SpectralisZeiss Cirrusgeneralizabilityretinal pigment epithelium drusen complextotal retinal volumesdrusenmachine learningretinal image analysis1 IntroductionSpectral-domain optical coherence tomography (SD-OCT) images are commonly used for the diagnosis and monitoring of outer retinal diseases, such as age-related macular degeneration (AMD) [1], [2], [3].
-
Mar 30, 2024 | 
medium.com | Emily Y. Chew
In this blog post, I’ll be sharing my experience and reflections on my journey with React JS, along with insights into my first React project, an e-commerce website for games called Crux Games. After completing the Vanilla JavaScript phase of my boot camp, I transitioned into the world of React, a JavaScript library for building user interfaces.
-
Mar 7, 2024 | 00229-0/abstract?rss=yes&sz=64)
thelancet.com | Emily Y. Chew |Clinical Applications
Age-related macular degeneration (AMD), a leading cause of blindness, is projected to affect 288 million people globally in 2040 from an estimate of 196 million in 2020.The vision-threatening late forms of the disease include neovascular AMD (nAMD) and geographical atrophy.
-
Feb 9, 2024 | 
medium.com | Emily Y. Chew
I’ll be sharing my reflections, thoughts, and what I’ve learned so far in my JavaScript learning period. I’ll also be sharing my first JavaScript project and the process behind it. In this phase of my software engineering bootcamp journey, I’ve learned different aspects of JavaScript, which is one of the main programming languages of web development. I started off learning JavaScript fundamentals, such as variables, functions, and scoping.
-
Nov 2, 2023 | 
nature.com | Charles C. Wykoff |Ehsan Ullah |Emily Y. Chew |Wadih M. Zein |Mark McCarthy |Jeffrey Hofmann | +1 more
AbstractAge-related macular degeneration (AMD), a complex neurodegenerative disease, is a leading cause of visual impairment worldwide with a strong genetic component. Genetic studies have identified several loci, but few causal genes with functional characterization. Here we highlight multiple lines of evidence which show a causal role in AMD for SLC16A8, which encodes MCT3, a retinal pigment epithelium (RPE) specific lactate transporter.
-
Aug 10, 2023 | 00113-6/abstract&sz=64)
ophthalmologyscience.org | Emily Y. Chew
Data science is one of several foci of Ophthalmology Science, the latest journal to join the American Academy of Ophthalmology journal family. The inaugural special issue of Ophthalmology Science was devoted to artificial intelligence and big data/data science. 1Lee C.S. Brandt J.D. Lee A.Y. Big data and artificial intelligence in ophthalmology: where are we now?. Ophthalmol Sci.
-
Aug 9, 2023 | 00110-0/abstract&sz=64)
ophthalmologyscience.org | Emily Y. Chew |Clinical Applications |Leanne T. Labriola
Several patient-reported outcome measures (PROMs) are available to measure health-related quality of life (HRQoL) in patients with late stage clinical diabetic retinal diseases (DRD). However, an understanding of the psychometric properties of PROMs is needed to assess how they could relate to severity levels of a revised DRD grading system. This narrative review assesses the available generic-, vision- and DRD-related PROMs used in DRD research and highlights areas for improvement.
-
Aug 7, 2023 | 
healio.com | Emily Y. Chew |Anthony DeFino |Christine Klimanskis
Source/Disclosures
Source:
Chew E. Phase 3 randomized studies of efficacy and safety of revakinagene taroretcel producing ciliary neurotrophic factor (CNTF) in macular telangiectasia type 2. Presented at: American Society of Retina Specialists annual meeting; July 28-Aug. 1, 2023; Seattle.
Disclosures:
Chew reports no relevant financial disclosures.
We were unable to process your request. Please try again later.
-
Mar 20, 2023 | 
alz-journals.onlinelibrary.wiley.com | Elvira Agrón |Emily Y. Chew
Get access to the full version of this article. View access options below. Purchase Instant Access Item saved, go to cart 48-Hour online access $10.00 Details View the article/chapter PDF and any associated supplements and figures for a period of 48 hours. Article/Chapter can not be printed. Article/Chapter can not be downloaded. Article/Chapter can not be redistributed.
